Evidence map›Paper›PMID 40551895›Full record

ReviewFrontiers in rehabilitation sciences2025

A brief discussion on the role of calcitonin gene-related peptide in the efficacy of rehabilitation medicine.

Guan Zhencheng, Xue Aiguo

Abstract readReview
In one paragraph

Review in Frontiers in rehabilitation sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Guan ZhenchengDepartment of Acupuncture, Dongguan Hospital of Traditional Chinese Medicine, Dongguan, Guangdong, China.
Xue AiguoDepartment of Acupuncture, Dongguan Hospital of Traditional Chinese Medicine, Dongguan, Guangdong, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Calcitonin gene-related peptide (CGRP) is an active peptide composed of 37 amino acids that functions through specific receptors. It is widely distributed in small-diameter dorsal root ganglion neurons, trigeminal ganglion neurons, and nerve fibers innervating the spinal cord and brainstem dorsal horn. CGRP regulates various physiological functions, including vasodilation, inflammation modulation, and cardiac protection, and plays a key role in pain transmission. Pain is a global health challenge closely associated with the activity of neuropeptides such as CGRP. Although progress has been made in the application of CGRP in treating various diseases, research in the field of rehabilitation remains in its early stages. This article summarizes the roles of CGRP in peripheral nerve injury, central injury, cardiovascular rehabilitation, and pain rehabilitation. In terms of treatment, common physical therapies such as laser therapy and shock wave therapy have been shown to influence CGRP expression levels. However, the specific effects of these physical interventions on CGRP require more systematic future research and analysis to achieve more efficient and personalized rehabilitation strategies.

Indexed as

calcitonin gene-related peptide (CGRP)neuroprotectionpain managementphysical and rehabilitation medicinevasodilation

Identifiers

PMID40551895
PMCPMC12183239

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.